Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
12,683
datasets available to search
ShareScore release 0.9.0
Dataset results
12,683 results for “tolerability”
A Safety, Tolerability, and Efficacy Study of IBI314 in Patients With Mild to Moderate COVID-19
ClinicalTrials.gov study NCT05172141. IPD Sharing: NO. Countries: 1. Publications: 0.
Comparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple Sclerosis
ClinicalTrials.gov study NCT03493841. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum D
ClinicalTrials.gov study NCT04578756. IPD Sharing: YES. Countries: 2. Publications: 0.
Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks
ClinicalTrials.gov study NCT07014007. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects
ClinicalTrials.gov study NCT04488900. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AC-OLE-01-VA Tolerability Study in Healthy Participants Under Different Dosing Conditions
ClinicalTrials.gov study NCT05628636. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Participant(s) With Autism and High Pain Tolerance Treated With High Dose Naltrexone
ClinicalTrials.gov study NCT05100563. IPD Sharing: NO. Countries: 1. Publications: 0.
This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD).
ClinicalTrials.gov study NCT05935085. IPD Sharing: NO. Countries: 7. Publications: 0.
A Study to Evaluate the Safety, Tolerability, Kinetics and Repeatability of 18F-BMS-986327
ClinicalTrials.gov study NCT04069143. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunogenicity, Safety, Tolerability and Ability to Prime for Memory of Meningococcal C Conjugate Vaccine in Healthy Children
ClinicalTrials.gov study NCT00311415. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study Aimed at Evaluation of the Effectiveness and Tolerability of an Anti-cellulite Cream Medical Device
ClinicalTrials.gov study NCT06348615. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
ClinicalTrials.gov study NCT05277168. IPD Sharing: UNDECIDED. Countries: 4. Publications: 0.
A Study In Healthy People To Investigate The Safety, Toleration And Time Course Of Blood Concentrations Of Multiple Doses Of PF-03654764, Given By Mouth
ClinicalTrials.gov study NCT00989391. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744
ClinicalTrials.gov study NCT00659191. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Safety,Tolerability,and Pharmacokinetics of Multiple-Ascending Dose JS1-1-01 in Healty Subjects.
ClinicalTrials.gov study NCT05656274. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study Of PF-04427429 In Healthy Women Volunteers
ClinicalTrials.gov study NCT01511497. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants
ClinicalTrials.gov study NCT05469360. IPD Sharing: NO. Countries: 4. Publications: 0.
Efficacy and Tolerability of the Tested Formula After 3 Months of Treatment of Facial Hyperpigmentation of 3 Origins
ClinicalTrials.gov study NCT06234527. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subje
ClinicalTrials.gov study NCT03140527. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Phase 2 Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AZ-3102 in Patients with GM2 Gangliosidosis or Niemann-Pick Type C Disease
ClinicalTrials.gov study NCT05758922. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.